RxDoctor Payments Data

Siddharth Chauhan

Houston, TXNPI 1942799705

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (50.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 55.9% of the total. Reporting peaked in 2024 at $23,832 and has fallen 56.3% since, to $10,405 in 2025.

$36,721in general payments, 2019–2025

Across 194 payments — averaging $189.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$21K
  • Abbott$7K
  • Boston Scientific$7K
  • Biosense Webster, Inc.$1K
  • Amgen$130
  • Angiodynamics, Inc.$125
  • plus $225 from 4 others

What the payments were for

  • Grants$18,50050%
  • Travel & lodging$7,75421%
  • Food & beverage$9,62326%
  • Education$8442%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →